NL-OMON43756已完成不适用
A Phase 1, Randomized, Double blind, Placebo Controlled, Single and Multiple Dose Escalation Study Evaluating Safety and Pharmacokinetics of VX 152 Alone and in Combination with VX 661/Ivacaftor, and Bioavailability and Food Effect of VX 152 in Healthy Adult Subjects - A Study to Evaluate Safety and PK of VX 152 in Healthy Adult Subjects
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male or female
- •18-55 y, incl.
- •BMI 18.0 - 31.0, and a total body weight >50 kg
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study
研究者
相似试验
尚未招募
1 期
A Study to Investigate the Safety of SEP-786 101 Capsules Compared With Placebo Capsules in Healthy Volunteer Participants Aged 24 Through 55 YearsHypoparathyroidismACTRN12624000898550Septerna, Inc.180
已完成
1 期
Assessment of the trial drugs ACH-0143102 and ACH-0142684, when taken by healthy men and women.ACTRN12614000102673Achillion Pharmaceuticals, Inc36
已完成
1 期
A Phase-I Clinical Trial to study the Safety and efficacy of Bharat Biotech International Limited Influenza A H1N1 pandemic 2009 Vaccine (Inactivated) in healthy volunteers.CTRI/2010/091/000152Bharat Biotech International Limited160
已完成
1 期
A Phase I Clinical Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses of RS1805 Tablets in Healthy Adult SubjectsInflammatory Bowel DiseaseACTRN12620000910909Atridia Pty Ltd88
撤回
1 期
EmtinB Safety, Tolerability and Pharmacokinetics (PK) Study in Healthy Participantseurodegenerative disordersNeurodegenerative disordersNeurological - Neurodegenerative diseasesACTRN12622001019796euroScientific Biopharmaceuticals Ltd72